Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Relationship between metalloproteinase 2 and 9 concentrations and soluble CD154 expression in Iranian patients with multiple sclerosis.
B cells in Multiple Sclerosis: Good or bad guys?: An article for 28 May 2014 - World MS Day 2014.
The case for measuring anti-drug antibodies in people with multiple sclerosis.
Low Prevalence of Sleep Disorders in Demyelinating Disease in a Northern Tenerife Population.
A review on ROCK-II inhibitors: From molecular modelling to synthesis.
Validation of the automated method VIENA: An accurate, precise, and robust measure of ventricular enlargement.
Copper/zinc chelation by clioquinol reduces spinal cord white matter damage and behavioral deficits in a murine MOG-induced multiple sclerosis model.
Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature.
Sequencing the immunopathologic heterogeneity in multiple sclerosis.
Anti-CD20 antibody wows in multiple sclerosis.
Interleukin-10 Gene-transfected Mature Dendritic Cells Suppress Murine Experimental Autoimmune Optic Neuritis.
Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid.
A randomised controlled trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the step it up study protocol.
Dietary Yeasts Reduce Inflammation in Central Nerve System via Microflora.
Neuromyelitis optica spectrum disorders with multiple brainstem manifestations: a case report.
Injury to white matter tracts in relapsing-remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics.
Seropositive Neuromyelitis Optica: A Pediatric Case Report and 6-Year Follow-Up.
Reduced field-of-view DTI segmentation of cervical spine tissue.
Clinical and demographic factors affecting disease severity in patients with multiple sclerosis.
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis.
Aquaporin 4 Expression and Tissue Susceptibility to Neuromyelitis Optica.
Use of a biomarker in exposure-response analysis to support dose selection for fingolimod.
The effects of a group-based cognitive behavioral therapy on people with multiple sclerosis: a randomized controlled trial.
Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice.
Ontogeny and Functions of Central Nervous System Macrophages.

Pages